Prochlorperazine Maleate
NDC 67296-0027
Product Information
Prochlorperazine Maleate is a ANDA-approved product labeled by Redpharm Drug, Inc.. This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). It is supplied as a red product. This product entry covers the primary NDC 67296-0027 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
M;P2
Code Structure Chart
Product Details
What is NDC 67296-0027?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PROCHLORPERAZINE MALEATE (UNII: I1T8O1JTL6)
- PROCHLORPERAZINE (UNII: YHP6YLT61T) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- TRIACETIN (UNII: XHX3C3X673)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYDEXTROSE (UNII: VH2XOU12IE)
- STARCH, CORN (UNII: O8232NY3SJ)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 198365 - prochlorperazine maleate 10 MG Oral Tablet
- RxCUI: 198365 - prochlorperazine 10 MG Oral Tablet
- RxCUI: 198365 - prochlorperazine (as prochlorperazine maleate) 10 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.